ticagrelor
Also known as AR-C126532XX, AZD6140, Brilinta®, Brilique®, AZD 6140, AZD-6140, (1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-(1,2,3)triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol, (1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-(1,2,3)triazolo(4,5-D)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor, sold under the brand name Brilinta among others, is a medication used for the prevention of stroke, heart attack and other events in people with acute coronary syndrome, meaning problems with blood supply in the coronary arteries. It acts as a platelet aggregation inhibitor by antagonising the P2Y12 receptor. The drug is produced by AstraZeneca. thumb|90 mg tablet of Brilinta
Key facts
- Drug.Verifiedfields
- changed
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 443228756
- Drug.image
- Ticagrelor.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 200
- Drug.image2
- Ticagrelor ball-and-stick animation.gif
- Drug.tradename
- Brilinta, Brilique, others
- Drug.MedlinePlus
- a611050
- Drug.DailyMedID
- Ticagrelor
- Drug.pregnancy_AU
- B1
- Drug.routes_of_administration
- By mouth
- Drug.ATC_prefix
Article
13 sectionsContents
- Medical uses
- Contraindications
- Adverse effects
- Interactions
- Pharmacology
- Mechanism of action
- Pharmacokinetics
- Chemistry
- Research
- Comparison with related drugs
- With clopidogrel
- With prasugrel
- References
Ticagrelor, sold under the brand name Brilinta among others, is a medication used for the prevention of stroke, heart attack and other events in people with acute coronary syndrome, meaning problems with blood supply in the coronary arteries. It acts as a platelet aggregation inhibitor by antagonising the P2Y12 receptor. The drug is produced by AstraZeneca. thumb|90 mg tablet of Brilinta
The most common side effects include dyspnea (difficulty breathing), bleeding and raised uric acid level in the blood.
Gallery (4)
Connections
Categories
Adenosine diphosphate receptor inhibitorsAlcoholsCyclopropanesCYP3A4 inhibitorsDrugboxes which contain changes to verified fieldsDrugboxes which contain changes to watched fieldsDrugs developed by AstraZenecaDrugs with non-standard legal statusECHA InfoCard ID from WikidataFluoroarenesPropyl compoundsTriazolopyrimidines